CIVILICA We Respect the Science
Publisher of Iranian Journals and Conference Proceedings
Paper
title

Copper, zinc, and iron levels in myelodysplastic syndrome patients versus healthy subject

Credit to Download: 0 | Page Numbers 1 | Abstract Views: 102
Year: 2018
COI code: AFZMED02_034
Paper Language: English

How to Download This Paper

For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.

Authors Copper, zinc, and iron levels in myelodysplastic syndrome patients versus healthy subject

  Vahid Moazed - Department of internal medicine Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
  Elham Jafari - Pathology and Stem Cell Research Center, Pathology Department, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
  Jafari RashidiNezhad - Department of internal medicine Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
  Behjat Kalantari - Department of internal medicine Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

Abstract:

Introduction: Myelodysplastic syndrome (MDS) is a heterogeneous group of disorders characterized by peripheral cytopenias despite increased hematopoietic precursors (ineffectiveerythropoiesis). Myelodysplastic morphology of blood cells can be encountered not only in myelodysplastic syndrome but also in nonclonal disorders like infections, autoimmunedisorders, iron deficiency anemia, megaloblastic anemia, copper deficiency and etc. Copper deficiency is likely an underrecognized cause of anemia and neutropenia and could bemisdiagnosed as a myelodysplastic syndrome (MDS) andCopper deficiency itself could induce dysplastic changes and iron overload. Some references such as Up to Date havesuggested that measurement of serum copper level should be performed as a diagnostic test for myelodysplastic syndrome but some other references such as williams ,didn’t mention that. So we decided to study the evaluation of serum iron, copper and zinc in patients with myelodysplastic symdrome in Bahonar hospital of Kerman(Iran) in 2016 to 2018.Method: 31 patients entered the study based on entry criteria .Serum Copper, iron,zinc , ceruloplasmin level were established , and bone marrow iron storages were evaluated basedon the results of bone marrow biopsies in 31 MDS patients. And we aslo selected the same control group with patient group and we measured their serum copper levels and thencompared them with patients. Results: 5 of 31 MDS patients were copper deficient(16.13%) Which was significant in comparison with the control group(p=0.02) .Mean serum copper level in patients with MDS was significantly lower than non-patients(p=0.0001)and Copper deficiency in these 5 patients was significantly associated with an increase in serum iron levels(0.001) but There was no significant difference in bone marrow Iron storage between patients with and without copper deficiency(p=0.2)and also no significant difference serum zinc between patients with and without copper deficiency . Conclusion: Copper deficiency is a frequent finding in MDS.It is desirable to include copperlevel determination in the initial workup of MDS.

Keywords:

serum iron, copper and zinc, myelodysplastic syndrome, ineffective erythropoiesis

Perma Link

https://www.civilica.com/Paper-AFZMED02-AFZMED02_034.html
COI code: AFZMED02_034

how to cite to this paper:

If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Moazed, Vahid; Elham Jafari; Jafari RashidiNezhad & Behjat Kalantari, 2018, Copper, zinc, and iron levels in myelodysplastic syndrome patients versus healthy subject, Second Afzali Pour International Medical Congress, كرمان, دانشگاه علوم پزشكي كرمان معاونت تحقيقات و فناوري - مركز تحقيقات پاتولوژي و سلول هاي بنيادي, https://www.civilica.com/Paper-AFZMED02-AFZMED02_034.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Moazed, Vahid; Elham Jafari; Jafari RashidiNezhad & Behjat Kalantari, 2018)
Second and more: (Moazed; Jafari; RashidiNezhad & Kalantari, 2018)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)